Abstract
Impaired cognitive flexibility in visual reversal-learning tasks has been observed in a wide range of neurological and neuropsychiatric disorders. Although both human and animal studies have implicated striatal D2-like and D1-like receptors (D2R; D1R) in this form of flexibility, less is known about the contribution they make within distinct sub-regions of the striatum and the different phases of visual reversal learning. The present study investigated the involvement of D2R and D1R during the early (perseverative) phase of reversal learning as well as in the intermediate and late stages (new learning) after microinfusions of D2R and D1R antagonists into the nucleus accumbens core and shell (NAcC; NAcS), the anterior and posterior dorsomedial striatum (DMS) and the dorsolateral striatum (DLS) on a touchscreen visual serial reversal-learning task. Reversal learning was improved after dopamine receptor blockade in the nucleus accumbens; the D1R antagonist, SCH23390, in the NAcS and the D2R antagonist, raclopride, in the NAcC selectively reduced early, perseverative errors. In contrast, reversal learning was impaired by D2R antagonism, but not D1R antagonism, in the dorsal striatum: raclopride increased errors in the intermediate phase after DMS infusions, and increased errors across phases after DLS infusions. These findings indicate that D1R and D2R modulate different stages of reversal learning through effects localised to different sub-regions of the striatum. Thus, deficits in behavioral flexibility observed in disorders linked to dopamine perturbations may be attributable to specific D1R and D2R dysfunction in distinct striatal sub-regions.
Highlights
Cognitive flexibility, the ability to adapt behavior to changes in the environment, is impaired in a wide range of neurological and neuropsychiatric disorders, including schizophrenia [1], obsessivecompulsive disorder (OCD) [2], Parkinson’s disease (PD) [3] and substance use disorder [4]
Rats were excluded from the study if the injector cannulas were positioned outside the target areas (n = 3 pDMS, n = 5 dorsolateral striatum (DLS) and n = 1 nucleus accumbens core and shell (NAcC))
Effects of intra-striatal infusions of the D2-like receptors (D2R) antagonist raclopride and the D1-like receptors (D1R) antagonist SCH23390 Across all behavioral variables we found no significant differences between the anterior over the posterior DMS (aDMS) and pDMS
Summary
The ability to adapt behavior to changes in the environment, is impaired in a wide range of neurological and neuropsychiatric disorders, including schizophrenia [1], obsessivecompulsive disorder (OCD) [2], Parkinson’s disease (PD) [3] and substance use disorder [4]. Such cognitive dysfunction can be evaluated in reversal-learning tasks. Pharmacological activation of D1-like receptors (D1R) impaired early phases of reversal learning [8], whereas D1R antagonism did not alter reversal learning performance [5]. Repeat variations in the dopamine transporter gene, DAT1, have been linked to performance during the early, perseverative phase of reversal learning, when prior beliefs about the stimulus-reward outcomes still guide behavior, whereas accuracy during later phases, when new learning takes place, showed no such link [9]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.